391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)
Pill with imprint 391 G is Purple, Elliptical / Oval and has been identified as Carbidopa and levodopa extended release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 391 G
- 391 G
- 50 mg / 200 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Global Pharmaceuticals
- Inactive Ingredients:
- hydroxypropyl cellulose
FD&C Blue No. 2
FD&C Red No. 40
Note: Inactive ingredients may vary.
More about carbidopa/levodopa
- Carbidopa/levodopa Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 53 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
- Carbidopa and levodopa
- Carbidopa and levodopa enteral
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Carbidopa and Levodopa Sustained-Release Tablets
- Carbidopa and Levodopa Tablets
- ... +4 more
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.